Gene: CPS1
Official Full Name: carbamoyl-phosphate synthase 1provided by HGNC
Gene Summary: The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07157 | CPS1 Knockout cell line (HeLa) | Human | CPS1 | 1:3~1:6 | Negative | Online Inquiry |
KO07158 | CPS1 Knockout cell line (HCT 116) | Human | CPS1 | 1:2~1:4 | Negative | Online Inquiry |
KO07159 | CPS1 Knockout cell line (HEK293) | Human | CPS1 | 1:3~1:6 | Negative | Online Inquiry |
KO07160 | CPS1 Knockout cell line (A549) | Human | CPS1 | 1:3~1:4 | Negative | Online Inquiry |
CPS1 Gene Knockout Cell Lines are meticulously engineered cellular models created to study the role of the Carbamoyl Phosphate Synthetase 1 (CPS1) gene, which is essential for the urea cycle. The CPS1 enzyme catalyzes the conversion of ammonia and bicarbonate into carbamoyl phosphate, a critical step for detoxifying ammonia in mammals. These knockout cell lines are invaluable tools for investigating metabolic disorders associated with ammonia toxicity and shedding light on urea cycle dysfunction.
The functionality of these cell lines relies on CRISPR-Cas9 gene-editing technology, which precisely disrupts the CPS1 gene, resulting in the loss of CPS1 expression and activity. Researchers can use these cell lines to study the downstream effects of CPS1 deficiency, investigate compensatory metabolic pathways, and assess potential therapeutic interventions in conditions such as hyperammonemia and related disorders. The innovative design of these models allows for reproducible and controlled studies, providing a platform for a variety of assays, including drug screening and metabolic profiling.
CPS1 Gene Knockout Cell Lines are scientifically significant in both research and clinical contexts, advancing our understanding of metabolic diseases and facilitating the development of treatments. Compared to traditional cell lines, these specific knockout models enable more refined studies into the pathology associated with CPS1 deficiency, thus providing greater insight into the urea cycle's role in human health.
The unique advantages of our CPS1 Gene Knockout Cell Lines include their high specificity, minimal off-target effects, and versatility for a range of experimental setups. For researchers seeking to explore metabolic pathways and potential gene therapies, these cell lines offer a cutting-edge solution that exceeds the capabilities of non-targeted models.
As a leader in engineered cellular technologies, our company brings years of expertise in genetic manipulation and cell line development. We are committed to providing innovative products that empower researchers and clinicians to advance their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.